Clinical Trial Nuedexta in Subjects With ALS
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Richard A Smith, MD
Center for Neurologic Study (CNS)
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- California Pacific Medical Center
San Francisco, California, United States
- Georgetown University Medical Center
Washington D.C., District of Columbia, United States
- Saint Mary'S Health Care
Grand Rapids, Michigan, United States
- Hennepin County Medical Center
Minneapolis, Minnesota, United States
- Neurology Associates, P.C.
Lincoln, Nebraska, United States
- the Cleveland Clinic
Cleveland, Ohio, United States
- Providence Als Center
Portland, Oregon, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2013
- Primary completion
- 31 Mar 2015
- Completion
- 31 Mar 2015
- Last update posted
- 24 Mar 2017
- Registered enrollment
- 90
- Registry id
- NCT01806857
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.